Company Profile

Transposagen Biopharmaceuticals Inc
Profile last edited on: 7/1/19      CAGE: 499Y3      UEI:

Business Identifier: Animal models of human diseases for drug discovery and development
Year Founded
2003
First Award
2005
Latest Award
2016
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

535 West Second Street Suite L102
Lexington, KY 40508
   (859) 428-8561
   info@transposagenbio.com
   www.transposagenbio.com
Location: Single
Congr. District: 06
County: Fayette

Public Profile

Transposagen Biopharmaceuticals, Inc., a biotechnology company providing animal models, cell lines, stem cells, and research tools and technologies to improve drug discovery and development research offers site-specific nucleases targeting various genes in the human genome; genetically modified rat models, including knockout, knock-in, humanized, conditional, transgenic, and inducible rats; and rat tissues, custom rat models, in-bred and out-bred transgenic services, various disease models, and cell line and stem cell services. The firm offers its animal models for various human diseases, including human cardiovascular diseases, diabetes, and arthritis, as well as various autoimmune, neurological, and behavioral disorders. Transposgen's genetically modified animals using multiple genetic manipulation technologies - to include proprietary mobile DNA piggyBac technology and spermatogonial stem cells - serves pharmaceutical and biotechnology companies, academic laboratories and health institutes worldwide.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Eric M Ostertag -- CEO

  Jack Crawford -- Vice President, Business Development

  Blaire B Madison

  Joseph C Ruiz -- Vice President of Research Grants